Provenance du réseau au premier degré de R. Weslie Tyson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à R. Weslie Tyson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Chief Executive Officer | |
| BIOMÉRIEUX | Medical Specialties | Corporate Officer/Principal | |
| MYRIAD GENETICS, INC. | Medical Specialties | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Utah | College/University | Masters Business Admin | |
| Fudan University | College/University | Undergraduate Degree | |
| SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD | Medical Specialties | President | |
| Southern Illinois University | College/University | Graduate Degree | |
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Medical Specialties | Chief Executive Officer | |
| Combimatrix Molecular Diagnostics, Inc. | Corporate Officer/Principal | ||
| University of California, Davis | College/University | Undergraduate Degree | |
| University of California, Irvine | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Chine | 4 |
| France | 2 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 6 |
| Health Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 2 |
| Masters Business Admin | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Richard Ding | 10 |
| Karine Hovanes | 4 |
- Bourse
- Insiders
- R. Weslie Tyson
- Connexions Sociétés
